Gut Microbiota and New Microbiome-Targeted Drugs for Clostridioides difficile InfectionsAhran Lee(Korea National Institute of Health), Eun-Jeong Yoon(Seoul National University)AntibioticsOctober 20, 202410.3390/antibiotics13100995Cited by 4SaveCiteExport RISWatch citationsRelated PapersSafety and efficacy of durvalumab following trimodality therapy for locally advanced esophageal and GEJ adenocarcinoma: Early efficacy results from Big Ten Cancer Research Consortium study.|Journal of Clinical Oncology|2019|10Safety and efficacy of durvalumab following multimodality therapy for locally advanced esophageal adenocarcinoma: Early results from Big Ten Cancer Research Consortium study.|Journal of Clinical Oncology|2018|0